Literature DB >> 33928521

Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females.

Annie Tsz-Wai Chu1,2, Desiree Man-Sik Tse3, Dacita To Ki Suen1, Ava Kwong4,5,6,7.   

Abstract

Limited studies have examined the pre-counselling knowledge and attitudes of high-risk women on hereditary breast and ovarian cancer (HBOC) syndromes genetic screening in Asia Pacific regions, particularly among Chinese. After controlling cost, an intrinsic barrier to undertake such screening, comprehensive understanding of the baseline characteristics of this cohort towards HBOC genetic counselling and testing service (GT) could be sought. This study aimed at exploring the baseline knowledge, possible motivators, barriers, and decisional factors of undertaking such service. One hundred and forty-two Southern Hong Kong Chinese high-risk females (89.4% with cancer history; 10.6% were cancer-free at-risk family members) completed a questionnaire right before their pre-testing GT. Results showed that perceived benefits to self and family members with reference to cancer prevention are important decisional motivators. A sponsored cancer genetic testing service in this cohort was crucial as 71.3% would not have opted for self-financed screening. Pre-testing and post-testing counselling were essential, particularly for older and less educated high-risk individuals. More importantly, after thorough pre-counselling with Q&A session, the entire cohort in this study gave written consent to undertake GT. Moreover, those proven to be germline pathogenic variant carriers were willing to share the information with family members and successfully persuaded them to pursue GT.

Entities:  

Keywords:  BRCA1/2; Chinese; Genetic counselling; Genetic testing; Hereditary breast cancer

Year:  2021        PMID: 33928521     DOI: 10.1007/s12687-021-00518-3

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  16 in total

1.  Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.

Authors:  Deborah Cragun; Anne Weidner; Courtney Lewis; Devon Bonner; Jongphil Kim; Susan T Vadaparampil; Tuya Pal
Journal:  Cancer       Date:  2017-02-09       Impact factor: 6.860

2.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

3.  Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians.

Authors:  Tan-Min Chin; Sing-Huang Tan; Siew-Eng Lim; Philip Iau; Wei-Peng Yong; Seng-Weng Wong; Soo-Chin Lee
Journal:  Cancer Detect Prev       Date:  2005-09-23

4.  Prevention and treatment of mental illness in the People's Republic of China.

Authors:  D Y Ho
Journal:  Am J Orthopsychiatry       Date:  1974-07

5.  Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.

Authors:  Susan M Domchek; Carol Aghajanian; Ronnie Shapira-Frommer; Rita K Schmutzler; M William Audeh; Michael Friedlander; Judith Balmaña; Gillian Mitchell; Georgeta Fried; Salomon M Stemmer; Ayala Hubert; Ora Rosengarten; Niklas Loman; Jane D Robertson; Helen Mann; Bella Kaufman
Journal:  Gynecol Oncol       Date:  2015-12-23       Impact factor: 5.482

6.  Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.

Authors:  Joanne Armstrong; Michele Toscano; Nancy Kotchko; Sue Friedman; Marc D Schwartz; Katherine S Virgo; Kristian Lynch; James E Andrews; Claudia X Aguado Loi; Joseph E Bauer; Carolina Casares; Elizabeth Bourquardez Clark; Matthew R Kondoff; Ashley D Molina; Mehrnaz Abdollahian; Gregg Walker; Rebecca Sutphen
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

7.  Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.

Authors:  D Cragun; D Bonner; J Kim; M R Akbari; S A Narod; A Gomez-Fuego; J D Garcia; S T Vadaparampil; Tuya Pal
Journal:  Breast Cancer Res Treat       Date:  2015-04-14       Impact factor: 4.872

Review 8.  "Decoding hereditary breast cancer" benefits and questions from multigene panel testing.

Authors:  Chrystelle Colas; Lisa Golmard; Antoine de Pauw; Sandrine M Caputo; Dominique Stoppa-Lyonnet
Journal:  Breast       Date:  2019-01-08       Impact factor: 4.380

9.  Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism.

Authors:  Elizabeth P Hayden; Lea R Dougherty; Bryan Maloney; Thomas M Olino; Haroon Sheikh; C Emily Durbin; John I Nurnberger; Debomoy K Lahiri; Daniel N Klein
Journal:  J Affect Disord       Date:  2007-09-04       Impact factor: 4.839

Review 10.  Lifestyle, genes, and cancer.

Authors:  Yvonne M Coyle
Journal:  Methods Mol Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.